U.S. Markets closed

Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher

Zacks Equity Research

Furiex Pharmaceuticals, Inc. (FURX) was a big mover last session, as the company saw its shares rise by roughly 29% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. . This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $75.24 to $93.14 in the past one-month time frame.

This generic drug company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Furiex Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Biomerica Inc. (BMRA), Bio-Path Holdings, Inc. (BPTH) and Cell Therapeutics, Inc. (CTIC). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


BIOMERICA INC (BMRA): Free Stock Analysis Report

BIO PATH HOLDINGS INC (BPTH): Free Stock Analysis Report

CELL THERAPEUTICS INC (CTIC): Free Stock Analysis Report

Zacks Investment Research